Pettit K - Search Results

1

Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up.

Khouderchah CJ, Benitez LL, Marini BL, Fraga M, Pettit K, Burke PW, Bixby DL, Perissinotti AJ. Khouderchah CJ, et al. Among authors: pettit k. Leuk Lymphoma. 2024 Feb;65(2):228-234. doi: 10.1080/10428194.2023.2276056. Epub 2024 Jan 24. Leuk Lymphoma. 2024. PMID: 37933203

2

Novel Therapies for Myelofibrosis.

Pettit K, Odenike O. Pettit K, et al. Curr Hematol Malig Rep. 2017 Dec;12(6):611-624. doi: 10.1007/s11899-017-0403-0. Curr Hematol Malig Rep. 2017. PMID: 29098608 Free PMC article. Review.

3

Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia.

Pettit K, Stock W, Walter RB. Pettit K, et al. Leuk Lymphoma. 2016 Jul;57(7):1527-33. doi: 10.3109/10428194.2016.1160085. Leuk Lymphoma. 2016. PMID: 27269126 Free PMC article. Review.

4

The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.

Cheung E, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Benitez LL, Brown J, Scappaticci GB, Marini BL. Cheung E, et al. Ann Hematol. 2019 Mar;98(3):541-559. doi: 10.1007/s00277-019-03606-0. Epub 2019 Jan 21. Ann Hematol. 2019. PMID: 30666431 Review.

5

Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction.

Robinson AC, Marini BL, Pettit KM, Perissinotti AJ. Robinson AC, et al. J Oncol Pharm Pract. 2020 Jan;26(1):200-205. doi: 10.1177/1078155219829534. Epub 2019 Feb 13. J Oncol Pharm Pract. 2020. PMID: 30760167

6

A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage.

Marini BL, Brown J, Benitez L, Walling E, Hutchinson RJ, Mody R, Jasty Rao R, Slagle L, Bishop L, Pettit K, Bixby DL, Burke PW, Perissinotti AJ. Marini BL, et al. Among authors: pettit k. Leuk Lymphoma. 2019 Dec;60(12):2854-2868. doi: 10.1080/10428194.2019.1608530. Epub 2019 May 17. Leuk Lymphoma. 2019. PMID: 31099289

7

Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Marini BL, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Benitez LL. Marini BL, et al. Cancer. 2019 Nov 1;125(21):3890-3891. doi: 10.1002/cncr.32381. Epub 2019 Jul 10. Cancer. 2019. PMID: 31291001 Free article. No abstract available.

8

Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia.

Alsawah F, Benitez L, Choi S, Marini B, Perissinotti A, Skyles A, Burke P, Pettit K, Crouch A, Fox H, Bixby D. Alsawah F, et al. Among authors: pettit k. Blood Adv. 2019 Nov 12;3(21):3333-3336. doi: 10.1182/bloodadvances.2019000289. Blood Adv. 2019. PMID: 31698446 Free PMC article.

9

Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.

Reid JH, Perissinotti AJ, Benitez L, Bixby DL, Burke P, Pettit K, Marini BL. Reid JH, et al. Among authors: pettit k. Leuk Lymphoma. 2020 Apr;61(4):862-868. doi: 10.1080/10428194.2019.1691199. Epub 2019 Nov 18. Leuk Lymphoma. 2020. PMID: 31739707

10

Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.

Ochs MA, Perissinotti AJ, Marini BL, Burke PW, Bixby DL, Pettit KM, Benitez LL. Ochs MA, et al. Leuk Res. 2021 Mar;102:106517. doi: 10.1016/j.leukres.2021.106517. Epub 2021 Jan 26. Leuk Res. 2021. PMID: 33561633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page